Calliditas Therapeutics AB Net Profit Margin 2020-2020 | CALT

Calliditas Therapeutics AB net profit margin from 2020 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Calliditas Therapeutics AB Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-03-31 $0.02B $-0.01B -25.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.601B $0.020B
Calliditas Therapeutics AB is a specialty pharmaceutical company. It is focused on developing pharmaceutical products for patients with a significant unmet medical need. The compnay's lead candidate consist Nefecon. Calliditas Therapeutics AB is based in Stockholm, Sweden.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.197B 43.91
Takeda Pharmaceutical (TAK) Japan $52.178B 9.09
Astellas Pharma (ALPMY) Japan $25.637B 0.00
Eisai (ESALY) Japan $24.010B 20.29
UCB SA (UCBJF) Belgium $21.561B 0.00
Merck (MKGAF) Germany $20.291B 26.61
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $15.051B 48.92
Grifols, S.A (GRFS) Spain $12.307B 15.04
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 25.17
Neurocrine Biosciences (NBIX) United States $9.339B 36.15
Jazz Pharmaceuticals (JAZZ) Ireland $8.294B 13.72
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
IPSEN SA ADR (IPSEY) France $7.818B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.563B 41.58
Arrowhead Pharmaceuticals (ARWR) United States $6.310B 0.00
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $5.480B 12.67
Evotec AG (EVTCY) Germany $4.517B 145.40
Sage Therapeutics (SAGE) United States $3.680B 0.00
ChemoCentryx (CCXI) United States $3.612B 0.00
PTC Therapeutics (PTCT) United States $3.606B 0.00
FibroGen (FGEN) United States $3.535B 0.00
Hypermarcas (HYPMY) Brazil $3.397B 12.49
Nektar Therapeutics (NKTR) United States $2.948B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.362B 11.43
Pacira BioSciences (PCRX) United States $2.253B 59.21
Xencor (XNCR) United States $2.221B 0.00
Revolution Medicines (RVMD) United States $2.170B 0.00
Corcept Therapeutics (CORT) United States $2.057B 18.94
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.030B 0.00
Cronos Group (CRON) Canada $1.952B 0.00
USANA Health Sciences (USNA) United States $1.762B 15.52
Ironwood Pharmaceuticals (IRWD) United States $1.536B 10.67
Heron Therapeutics (HRTX) United States $1.444B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.399B 13.34
Theravance Biopharma (TBPH) Cayman Islands $1.289B 0.00
Endo (ENDP) Ireland $1.257B 1.86
Trillium Therapeutics (TRIL) Canada $1.244B 0.00
Karyopharm Therapeutics (KPTI) United States $1.208B 0.00
Zogenix (ZGNX) United States $1.142B 0.00
Indivior (INVVY) United States $1.031B 12.78
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
Translate Bio (TBIO) United States $0.997B 0.00
ImmunoGen (IMGN) United States $0.962B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.903B 562.63
Esperion Therapeutics (ESPR) United States $0.874B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Tilray (TLRY) Canada $0.711B 0.00
Ocular Therapeutix (OCUL) United States $0.691B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.655B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.647B 32.29
Radius Health (RDUS) United States $0.641B 0.00
Collegium Pharmaceutical (COLL) United States $0.634B 0.00
Flexion Therapeutics (FLXN) United States $0.613B 0.00
VAXART, INC (VXRT) United States $0.596B 0.00
Siga Technologies (SIGA) United States $0.507B 54.08
Spectrum Pharmaceuticals (SPPI) United States $0.497B 0.00
Ardelyx (ARDX) United States $0.471B 0.00
Molecular Templates (MTEM) United States $0.465B 0.00
Aerie Pharmaceuticals (AERI) United States $0.462B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.433B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.417B 0.00
Organogenesis Holdings (ORGO) United States $0.416B 0.00
Altimmune (ALT) United States $0.389B 0.00
Harpoon Therapeutics (HARP) United States $0.387B 0.00
TherapeuticsMD (TXMD) United States $0.376B 0.00
Redhill Biopharma (RDHL) Israel $0.364B 0.00
DURECT (DRRX) United States $0.359B 0.00
Concert Pharmaceuticals (CNCE) United States $0.351B 0.00
Profound Medical (PROF) Canada $0.347B 0.00
Akebia Therapeutics (AKBA) United States $0.347B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.323B 8.00
Innate Pharma SA (IPHYF) France $0.323B 0.00
MEI Pharma (MEIP) United States $0.318B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.312B 0.00
Jounce Therapeutics (JNCE) United States $0.307B 14.52
Menlo Therapeutics (VYNE) United States $0.302B 0.00
KalVista Pharmaceuticals (KALV) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.268B 6.23
CASI Pharmaceuticals (CASI) United States $0.262B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
Rafael Holdings (RFL) United States $0.245B 0.00
CTI BioPharma (CTIC) United States $0.240B 0.00
Xeris Pharmaceuticals (XERS) United States $0.237B 0.00
Aduro Biotech (KDNY) United States $0.235B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.224B 0.00
IMV INC (IMV) Canada $0.223B 0.00
Nature's Sunshine Products (NATR) United States $0.213B 21.02
Oasmia Pharmaceutical AB (OASMY) Sweden $0.211B 0.00
Nivalis Therapeutics (ALPN) United States $0.186B 0.00
Aquestive Therapeutics (AQST) United States $0.182B 0.00
Otonomy (OTIC) United States $0.179B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.174B 0.00
Heat Biologics (HTBX) United States $0.174B 0.00
Aclaris Therapeutics (ACRS) United States $0.172B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.170B 0.00
OptiNose (OPTN) United States $0.161B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.158B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.105B 0.00
MediWound (MDWD) Israel $0.096B 0.00
Lipocine (LPCN) United States $0.088B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.081B 0.00
ProPhase Labs (PRPH) United States $0.080B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.074B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.073B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.071B 0.00
AgeX Therapeutics (AGE) United States $0.071B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.070B 0.00
Novan (NOVN) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.066B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Biomerica (BMRA) United States $0.064B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
Natural Alternatives (NAII) United States $0.053B 0.00
SCYNEXIS (SCYX) United States $0.049B 0.00
India Globalization Capital (IGC) United States $0.048B 0.00
Onconova Therapeutics (ONTX) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.18
Forward Pharma (FWP) Denmark $0.045B 0.00
Recro Pharma (REPH) United States $0.044B 0.00
PolarityTE (PTE) United States $0.040B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
Mannatechorporated (MTEX) United States $0.033B 8.40
Bellicum Pharmaceuticals (BLCM) United States $0.032B 0.00
GTx (ONCT) United States $0.031B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.031B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.027B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
IsoRay (ISR) United States $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 27.45
Sundial Growers (SNDL) Canada $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Vical (BBI) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.014B 0.00
Bio-Path Holdings (BPTH) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Iterum Therapeutics (ITRM) Ireland $0.010B 0.00
Shineco (TYHT) China $0.008B 0.00
JanOne (JAN) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00